PURPOSE: To identify the prevalence of psychological distress among women with ovarian cancer and to examine the association between these symptoms of distress and demographic and medical variables. PATIENTS AND METHODS: Participants were 143 women with ovarian cancer. Forty-eight percent of participants had been diagnosed with advanced-stage disease (stage III or IV) and most (80%) were currently receiving treatment. Psychological distress was assessed with the following measures: the Beck Depression Inventory, the Mental Health Inventory, the Impact of Events Scale, and a questionnaire regarding mental health service use. RESULTS: Approximately one fifth of women reported moderate to severe levels of distress, and more than half reported high stress responses to their cancer and its treatment. Most participants (60%) were not using any mental health services or psychotropic medications. There was also evidence to suggest that younger patients, patients with more advanced or recurrent disease, and patients who had more recently been diagnosed with ovarian cancer experienced greater psychological distress. CONCLUSION: These findings indicate that psychological distress and high stress responses to cancer are prevalent among women with ovarian cancer, suggesting they should be carefully evaluated to determine whether treatment for these symptoms is warranted.
PURPOSE: To identify the prevalence of psychological distress among women with ovarian cancer and to examine the association between these symptoms of distress and demographic and medical variables. PATIENTS AND METHODS: Participants were 143 women with ovarian cancer. Forty-eight percent of participants had been diagnosed with advanced-stage disease (stage III or IV) and most (80%) were currently receiving treatment. Psychological distress was assessed with the following measures: the Beck Depression Inventory, the Mental Health Inventory, the Impact of Events Scale, and a questionnaire regarding mental health service use. RESULTS: Approximately one fifth of women reported moderate to severe levels of distress, and more than half reported high stress responses to their cancer and its treatment. Most participants (60%) were not using any mental health services or psychotropic medications. There was also evidence to suggest that younger patients, patients with more advanced or recurrent disease, and patients who had more recently been diagnosed with ovarian cancer experienced greater psychological distress. CONCLUSION: These findings indicate that psychological distress and high stress responses to cancer are prevalent among women with ovarian cancer, suggesting they should be carefully evaluated to determine whether treatment for these symptoms is warranted.
Authors: Alaina J Brown; Megan J Shen; Lois M Ramondetta; Diane C Bodurka; Robert L Giuntoli; Teresa Diaz-Montes Journal: Int J Gynecol Cancer Date: 2014-10 Impact factor: 3.437
Authors: Jun-Mei Zhang; Pu Wang; Jia-xin Yao; Lei Zhao; Mellar P Davis; Declan Walsh; Guang H Yue Journal: Support Care Cancer Date: 2012-10-02 Impact factor: 3.603
Authors: Sharon L Manne; Shannon Myers-Virtue; Deborah A Kashy; Melissa Ozga; David Kissane; Carolyn Heckman; Mark Morgan Journal: Psychooncology Date: 2016-12-22 Impact factor: 3.894
Authors: Susan K Lutgendorf; George M Slavich; Koenraad Degeest; Michael Goodheart; David Bender; Premal H Thaker; Frank Penedo; Bridget Zimmerman; Joseph Lucci; Luis Mendez; Katherine Collins; Anil K Sood Journal: Gynecol Oncol Date: 2013-10-03 Impact factor: 5.482
Authors: Anna P B M Braeken; Lilian Lechner; Francis C J M van Gils; Ruud M A Houben; Daniëlle Eekers; Ton Ambergen; Gertrudis I J M Kempen Journal: BMC Cancer Date: 2009-06-09 Impact factor: 4.430